Cost of care and clinical condition in paediatric cystic fibrosis patients

Journal of Cystic Fibrosis

Volumn 2, Issue 2, 2003, Pages 84-90

  Baumann, Ulrich ^a,b   Stocklossa, Christiane ^b   Greiner, Wolfgang ^b   von der Schulenburg, Johann Matthias Graf ^b   von der Hardt, Horst ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Costs; Cystic fibrosis; Health economics; Prevention; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; DORNASE ALFA;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; CHILD; CHILD CARE; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; GERMANY; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOME CARE; HUMAN; INFANT; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PSEUDOMONAS AERUGINOSA; SENSITIVITY ANALYSIS;

ADOLESCENT; AGE FACTORS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COST OF ILLNESS; COST-BENEFIT ANALYSIS; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GERMANY; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH STATUS; HOSPITALS, UNIVERSITY; HUMANS; INSURANCE, HEALTH; MALE; NUTRITIONAL STATUS; OUTCOME ASSESSMENT (HEALTH CARE); PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0038309274     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-1993(03)00024-9     Document Type: Article

References (22)

1. Robinson P. Cystic fibrosis Thorax 56 2001 237-241
2. Welsh M.J. Tsui L.C. Boat T.F. Beaudet A.L. Cystic fibrosis In: Scriver C.R. Beaudet A.L. Sly W.S. Valle D. Stanbury J.B. Wyngaarden J.B. et-al, editors. The Metabolic and Molecular Bases of Inherited Disease 1995 3799-3876 McGraw-Hill New York (NY)
3. Sens B. Stern M. Wiedemann B. [Quality assurance in cystic fibrosis. Annual report of the German cystic fibrosis registry 2001.] Qualitätssicherung Mukoviszidose. Überblick über den Gesundheitszustand der Patienten in Deutschland 2001 Zentrum für Qualitätsmanagement im Gesundheitswesen Hannover
4. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry 2000 Annual Data Report 2001 Cystic Fibrosis Foundation Bethesda, MD
5. Zapletal A. Lung function testing in the assessment of lung involvement in cystic fibrosis Acta Univ Carol Med Praha 36 1990 183-194
6. Ramsey B.W. Farrell P.M. Pencharz P. Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee Am J Clin Nutr 55 1992 108-116
7. Crispin A.R. Norman A.P. The systematic evaluation of chest radiograph in cystic fibrosis Pediatr Radiol 2 1974 101-106
8. Ballmann M. Rabsch P. von der Hardt H. Long term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis Thorax 53 1998 732-737
9. Stern M. [Quality assurance in cystic fibrosis. Annual report of the German cystic fibrosis registry 1996.] Qualitätssicherung Mukoviszidose 1997 Zentrum für Qualitätsmanagement im Gesundheitswesen, Hannover Hannover, Germany
10. (no author). Einheitlicher Bewertungsmaßstab (EBM) mit den Vertragsgebührenordnungen Bewertungsmaßstab für ärztliche Leistungen (BMÄ) und Ersatzkassen-Gebührenordnung (E-GO), Stand 1. Juli 1996. Köln: Deutscher Ärzte-Verlag, 1996
11. (no author). Gebührenordnung für Ärzte und Zahnärzte. München: dtv (Beck-Texte), 1996
12. Bundesverband der Pharmazeutischen Industrie. Rote Liste 1996. Aulendorf: Cantor, 1996
13. Graf von der Schulenburg J.M. Greiner W. Gesundheitsökonomik 2000 Mohr Siebeck Tübingen
14. Statistisches Bundesamt der Bundesrepublik Deutschland. Statistisches Jahrbuch 2000. Stuttgart: Metzler-Poeschel, 2000
15. Doull I.J. Recent advances in cystic fibrosis Arch Dis Child 85 2001 62-66
16. Krauth C. Busse R. Smaczny C. Ullrich G. Wagner T.O. Weber J. et-al. Cost comparison of hospital and ambulatory i.v. therapy in adult cystic fibrosis patients. Results of a controlled prospective study Med Klin 94 1999 541-548
17. Lieu T.A. Ray G.T. Farmer G. Shay G.F. et-al. The cost of medical care for patients with cystic fibrosis in a health maintenance organization Pediatrics 103 1999 e72
18. Wildhagen M.F. Verheij J.B. Verzijl J.G. Hilderink H.B. Kooij L. Tijmstra T. et-al Cost of care of patients with cystic fibrosis in The Netherlands in 1990-91 Thorax 51 1996 298-301
19. Robson M. Abbott J. Webb K. Dodd M. Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients Thorax 47 1992 684-689
20. Johansen H.K. Kovesi T.A. Koch C. Corey M. Hoiby N. Levison H. Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen Pediatr Pulmonol 26 1998 89 96
21. Frederiksen B. Koch C. Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis Pediatr Pulmonol 23 1997 330-335
22. Baumann U. Fischer J.J. Gudowius P. Lingner M. Herrmann S. Tummler B. et-al. Buccal adherence of Pseudomonas aeruginosa in patients with cystic fibrosis under long-term therapy with azithromycin Infection 29 2001 7-11